You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Up until now, Agencourt's main focus has been on DNA sequencing and sample prep. Cogenics, which has facilities in four countries, also provides genotyping, gene-expression analysis, biological efficacy and safety testing, and a biobanking facility.
The technology that Transgenomic has licensed is a variation of standard PCR technology that enriches mutations in samples where normal DNA predominates.
The company plans to move ahead with assay development projects for diagnosing Alzheimer's and Parkinson's disease, and for detecting KRAS mutations in colorectal, lung, and pancreatic cancer.
Clinical Data will use the funds to support late-stage development of two of its drugs.
The firm said it only has enough cash to fund its operations through March, and it is evaluating a number of options including the sale of non-core assets or another financing.
Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.
The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.
The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.
In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.